as on October 17, 2025 at 1:29 am IST
Day's Low
Day's High
0.71%
Downside
7.14%
Upside
52 Week's Low
52 Week's High
75.79%
Downside
14.29%
Upside
Check Avalo Therapeutics Inc market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.
Market Cap
$249.0M
EPS (TTM)
-5.3783
Dividend Yield
0.00%
Quarterly Earnings Growth YOY
0.00%
PE Ratio (TTM)
2.14
Industry PE ratio
0PEG Ratio
0EBITDA
-59.8M
Revenue (TTM)
441.0K
Profit Margin
0.00%
Return On Equity TTM
-90.25%
Track how Avalo Therapeutics Inc P/E has moved over time to understand its valuation trends.
Avalo Therapeutics Inc in the last 5 years
Lowest (-172.90x)
June 30, 2022
Industry (0.00x)
October 16, 2025
Today (2.14x)
October 16, 2025
Highest (-0.02x)
March 31, 2024
Today’s Price to Earnings Ratio: 2.14x
Compare market cap, revenue, PE, and other key metrics of Avalo Therapeutics Inc with its industry peers.
Company | Analyst View | Market Cap | 5 Years Return % | PE Ratio | Profit Margin % |
---|---|---|---|---|---|
$249.0M | NA | 2.14 | 0.00% | ||
BUY | $61.5B | 223.43% | -505.15 | -12.96% | |
NA | $37.1B | NA | NA | -3.89% | |
BUY | $105.7B | 87.04% | 28.99 | 31.86% | |
BUY | $59.6B | -3.89% | 14.07 | 31.37% |
The Avalo Therapeutics Inc stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.
*Dollar Return is the profit earned when the US dollar rises in value compared to the Indian rupee.
Investment Value
₹1,00,000
Avalo Therapeutics Inc investment value today
Current value as on today
₹1,40,701
Returns
₹40,701
(+40.7%)
Returns from Avalo Therapeutics Inc Stock
₹36,054 (+36.05%)
Dollar Returns*
₹4,647 (+4.65%)
Based on 6 analysts
0.00%
Buy
50.00%
Hold
50.00%
Sell
Based on 6 analysts, 50% of analysts recommend a 'SELL' rating for Avalo Therapeutics Inc. Average target price of $32.29
Get share price movements and forecasts by analysts on Avalo Therapeutics Inc.
What analysts predicted
56.64%UPSIDE
Target Price
$32.29
Current Price
$14
Analyzed by
6 Analysts
Target
$32.29
Avalo Therapeutics Inc target price $32.29, a slight upside of 56.64% compared to current price of $14. According to 6 analysts rating.
Search interest for Avalo Therapeutics Inc Stock has increased by 147% in the last 30 days, reflecting an upward trend in search activity.
Time period: to
Change:147% versus previous 30 day period
All numbers in Millions USD
All numbers in Millions USD
All numbers in Millions USD
All numbers in Millions USD
Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.
Price Rise
In the last 3 months, AVTX stock has moved up by 145.6%
Against Peers
In the last 3 years, Alnylam Pharmaceuticals, Inc. has given 141.1% return, outperforming this stock by 240.0%
Against Peers
In the last 1 year, Alnylam Pharmaceuticals, Inc. has given 58.5% return, outperforming this stock by 24.8%
Profit Down
Netprofit is down for the last 2 quarters, -13.14M → -20.76M (in $), with an average decrease of 57.9% per quarter
Revenue Fall
Revenue is down for the last 3 quarters, 571.0K → 192.0K (in $), with an average decrease of 39.6% per quarter
Organisation | Avalo Therapeutics Inc |
Headquarters | 540 Gaither Road, Rockville, MD, United States, 20850 |
CEO | Dr. Garry A. Neil M.D. |
E-voting on shares | Click here to vote |
Name | Title |
---|---|
Dr. Garry A. Neil M.D. | President, CEO & Director |
Mr. Christopher Ryan Sullivan CPA | CFO & Head of Investor relations |
Dr. Mittie Doyle FACR, M.D. | Chief Medical Officer |
Dr. Solomon H. Snyder M.D. | Founder and Chairman of Scientific Advisory Board |
Mr. Paul C. Varki J.D., M.P.H | Chief Legal Officer |
Dr. Dino C. Miano Ph.D. | Senior Vice President of CMC & Technical Operations |
Dr. Barbara S. Slusher Ph.D. | Founder and Member of Scientific Advisory Board |
Ms. Ashley Ivanowicz | Senior Vice President of Human Resources |
Dr. Lisa Hegg Ph.D. | Senior Vice President of Program Management, Business Development & Corporate Infrastructure |
Ms. Colleen Matkowski | Senior Vice President of Global Regulatory Affairs & Quality Assurance |
Avalo Therapeutics Inc share price today is $14 as on at the close of the market. Avalo Therapeutics Inc share today touched a day high of $15 and a low of $13.9.
Avalo Therapeutics Inc share touched a 52 week high of $16 on and a 52 week low of $3.39 on . Avalo Therapeutics Inc stock price today i.e. is closed at $14,which is 12.50% down from its 52 week high and 312.98% up from its 52 week low.
Avalo Therapeutics Inc market capitalisation is $0.00T as on .
Indian investors can start investing in Avalo Therapeutics Inc (AVTX) shares with as little as ₹87.83 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹878.30 in Avalo Therapeutics Inc stock (as per the Rupee-Dollar exchange rate as on ).
Based on Avalo Therapeutics Inc share’s latest price of $14 as on October 17, 2025 at 1:29 am IST, you will get 0.7143 shares of Avalo Therapeutics Inc. Learn more about
fractional shares .